News for Cytosorbents Corporation (CTSO)

The Company reaffirms previously provided preliminary financial results for the quarter and full year ended December 31, 2024, and continues to expect regulato

PRINCETON, N.J., Feb. 26, 2025 (GLOBE NEWSWIRE) -- CytoSorbents Corporation ( CTSO), a leader in the treatment of life-threatening conditions in the intensive

1,417,208 Series A Right Warrants Exercised at $1.13 Per Share, Providing $1.6 Million in Aggregate Gross Proceeds PRINCETON, N.J., Feb. 25, 2025 (GLOBE NEW

San Francisco confirmed that a child in the city became the first case of H5N1. A panel of biotech leaders discussed what options could be taken next.

Oversubscribed Rights Offering Generated $6.25 Million in Aggregate Gross Proceeds Offering Proceeds Satisfies Debt Covenant, Unlocking $5.0 Million in Restric

PRINCETON, N.J., Jan. 06, 2025 (GLOBE NEWSWIRE) -- CytoSorbents Corporation ( CTSO), a leader in the treatment of life-threatening conditions in the intensive

Critical care company CytoSorbents Corp. (CTSO) announced Friday preliminary fourth-quarter results, expecting 22 percent to 25 percent growth in product revenue, while product gross margin would be lower.

CytoSorbents reports revenue growth in Q4

Fourth quarter product revenue growth estimated at 22% to 25% year-over-year Fourth quarter gross margin estimated to improve to approximately 70%

To Participate, Eligible Stockholders Should Consult Their Broker or Financial Advisor in Advance of the Rights Offering Expiration on January 10, 2025 PRINCE

Cytosorbents CFO Peter J. Mariani buys $19,294 in common stock

PRINCETON, N.J., Dec. 12, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation ( CTSO), a leader in the treatment of life-threatening conditions in the intensive

**media[487016]**

Triumph Financial reports quarterly results

Extracorporeal membrane oxygenation is performed to oxygenate the blood outside the body and to offer external circulatory support. Blood oxygenation is...

Shares of DouYu International Holdings Limited (NASDAQ: DOYU) rose sharply during Thursday’s session after announcing a share repurchase program.

/PRNewswire/ -- The "Europe Blood Purification Equipment Market 2021-2031 by Product (Hemodialysis, Blood Filtration, CRRT, Hemoperfusion, Plasma Exchange...

/PRNewswire/ -- The "Global Blood Purification Equipment Market 2021-2031 by Product (Hemodialysis, Blood Filtration, CRRT, Hemoperfusion, Plasma Exchange...

On Thursday, 615 stocks hit new 52-week lows. Noteable 52-Week Lows: Sea (NYSE:SE) is the largest company in terms of market cap to set a new ...